Key Points
The Centre informed the Supreme Court that it has decided to cap trade margins on anticancer drugs at 30% of the Maximum Retail Price (MRP).
The decision was considered at the 151st meeting of the National Pharmaceutical Pricing Authority (NPPA) on October 8, 2026.
The estimated annual savings for patients are approximately ₹2,500 crore.
An expert committee will identify eligible anti-cancer drugs, and the NPPA will issue the necessary price notifications.
The measure aims to improve medicine affordability and prevent excessive trade margins.

Important Terms
NPPA: National Pharmaceutical Pricing Authority.
DPCO, 2013: Drugs (Prices Control) Order, 2013.
MRP: Maximum Retail Price.
Paragraph 19 of DPCO, 2013: Empowers the government to act in the public interest to regulate drug prices.
Practice Questions
Prelims Question
Q. Under which provision of the DPCO, 2013, can the government use extraordinary powers to regulate drug prices?
A. Paragraph 5
B. Paragraph 10
C. Paragraph 19
D. Paragraph 25
Answer: C. Paragraph 19